'Coffee filter' helps make new cancer drug Z-endoxifen 1,000 times cheaper
- Details
- Category: Research
Making drugs cheaper doesn't always require pricey investments. A joint initiative by researchers from Eindhoven University of Technology (TU/e), the Dutch company Syncom BV and the Antoni van Leeuwenhoek hospital proves just that. What started out as a Bachelor project at TU/e laid the foundation for a much cheaper production of the promising cancer drug Z-endoxifen.
Researchers propose key elements of antimicrobial stewardship for hospitals worldwide
- Details
- Category: Research
Antimicrobial stewardship programs (ASPs) in hospitals play a vital role in managing the threat of antibiotic resistance. To be of maximum effectiveness, essential elements of ASP programs need to be identified and standardized. Previous efforts in identifying the key components of ASPs have been confined to high-income countries. In a study to be published in the journal Clinical Microbiology and Infection, researchers identify essential elements of ASPs that could be applicable to hospitals in both high-income and low-income countries.
When drugs are wrong, skipped or make you sick: The cost of non-optimized medications
- Details
- Category: Research
Rising drug prices have gotten a lot of attention lately, but the actual cost of prescription medications is more than just the dollars and cents on the bill. Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego estimate that illness and death resulting from non-optimized medication therapy costs $528.4 billion annually, equivalent to 16 percent of total U.S. health care expenditures in 2016.
Researchers identify chemical compound that inhibits Ebola virus replication
- Details
- Category: Research
An organic chemical compound shows effective antiviral activity against Ebola virus and several other viruses, according to a study led by Georgia State University. The researchers found benzoquinoline inhibited the ability of Ebola virus to multiply and reproduce in cell culture. The findings are published in the journal Antiviral Research.
Taking a standard prostate cancer drug with food boosts impact, lowers cost
- Details
- Category: Research
By taking a high-cost drug with a low-fat meal - instead of on an empty stomach, as prescribed - prostate cancer patients could decrease their daily dose, prevent digestive issues and cut costs by 75 percent, according to a new study in the March 28, 2018, issue of the Journal of Clinical Oncology (JCO).
Canadian neuroscientists say daily ibuprofen can prevent Alzheimer's disease
- Details
- Category: Research
A Vancouver-based research team led by Canada's most cited neuroscientist, Dr. Patrick McGeer, has successfully carried out studies suggesting that, if started early enough, a daily regimen of the non-prescription NSAID (nonsteroidal anti-inflammatory drug) ibuprofen can prevent the onset of Alzheimer's disease. This means that by taking an over-the-counter medication, people can ward off a disease that,
New targeted therapy schedule could keep melanoma at bay
- Details
- Category: Research
Skin melanoma, a particularly insidious cancer, accounts for the vast majority skin cancer deaths and is one of the most common cancers in people under 30. Treatment for advanced melanoma has seen success with targeted therapies - drugs that interfere with division and growth of cancer cells by targeting key molecules - especially when multiple drugs are used in combination. While the combination of targeted therapies improves patient outcomes, any remaining cancer cells can lead to drug resistance.
More Pharma News ...
- First proof a synthesized antibiotic is capable of treating superbugs
- North and south cooperation to combat tuberculosis
- Medicating for mental health
- Medical expansion has improved health - with one exception
- Stem cells treat macular degeneration
- Medicinal cannabis is safe and effective - it's time to reboot research
- 'Body on a chip' could improve drug evaluation